Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Carmona-Garcia MC"'
Autor:
Pinato, DJ, Aguilar-Company, J, Ferrante, D, Hanbury, G, Bower, M, Salazar, R, Mirallas, O, Sureda, A, Plaja, A, Cucurull, M, Mesia, R, Townsend, S, Jackson, A, Dalla Pria, A, Newsom-Davis, T, Handford, J, Sita-Lumsden, A, Apthorp, E, Vincenzi, B, Bertuzzi, A, Brunet, J, Lambertini, M, Maluquer, C, Pedrazzoli, P, Biello, F, Sinclair, A, Bawany, S, Khalique, S, Rossi, S, Rogers, L, Murphy, C, Belessiotis, K, Carmona-Garcia, MC, Sharkey, R, Garcia-Illescas, D, Rizzo, G, Perachino, M, Saoudi-Gonzalez, N, Doonga, K, Fox, L, Roldan, E, Gaidano, G, Ruiz-Camps, I, Bruna, R, Patriarca, A, Martinez-Vila, C, Cantini, L, Zambelli, A, Giusti, R, Mazzoni, F, Caliman, E, Santoro, A, Grosso, F, Parisi, A, Queirolo, P, Aujayeb, A, Rimassa, L, Prat, A, Tucci, M, Libertini, M, Grisanti, S, Mukherjee, U, Diamantis, N, Fusco, V, Generali, D, Provenzano, S, Gennari, A, Tabernero, J, Cortellini, A
Publikováno v:
LANCET ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background The omicron (B.1.1.529) variant of SARS-CoV-2 is highly transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due to COVID-19 during the omicron outbreak compared with the prevaccination period and alpha (B.1.1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4a67786bb4e1096fb306c45ffab05396
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7192
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7192
Autor:
Pinato DJ, Zambelli A, Aguilar-Company J, Bower M, Sng C, Salazar R, Bertuzzi A, Brunet J, Mesia R, Segui E, Biello F, Generali D, Grisanti S, Rizzo G, Libertini M, Maconi A, Harbeck N, Vincenzi B, Bertulli R, Ottaviani D, Carbo A, Bruna R, Benafif S, Marrari A, Wuerstlein R, Carmona-Garcia MC, Chopra N, Tondini C, Mirallas O, Tovazzi V, Betti M, Provenzano S, Fotia V, Cruz CA, Dalla Pria A, D'Avanzo F, Evans JS, Saoudi-Gonzalez N, Felip E, Galazi M, Garcia-Fructuoso I, Lee AJX, Newsom-Davis T, Patriarca A, Garcia-Illescas D, Reyes R, Dileo P, Sharkey R, Wong YNS, Ferrante D, Marco-Hernandez J, Sureda A, Maluquer C, Ruiz-Camps I, Gaidano G, Rimassa L, Chiudinelli L, Izuzquiza M, Cabirta A, Franchi M, Santoro A, Prat A, Tabernero J, Gennari A
Publikováno v:
Cancer Discovery
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
The SARS-Cov-2 pandemic significantly impacted on oncology practice across the globe. There is uncertainty as to the contribution of patients' demographics and oncological features on severity and mortality from Covid-19 and little guidance as to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::040e4a589c765a892bbec1b99c266a70
http://hdl.handle.net/10044/1/81253
http://hdl.handle.net/10044/1/81253
Autor:
Luque-Fernandez MA, Redondo-Sanchez D, Lee SF, Rodríguez-Barranco M, Carmona-García MC, Marcos-Gragera R, Sánchez MJ
Publikováno v:
Clinical Epidemiology, Vol Volume 12, Pp 31-40 (2020)
Miguel Angel Luque-Fernandez, 1–3 Daniel Redondo-Sanchez, 1, 3, 4 Shing Fung Lee, 5 Miguel Rodríguez-Barranco, 1, 3, 4 Ma Carmen Carmona-García, 6–8 Rafael Marcos-Gragera, 3, 6, 7, 9 María-José Sánchez 1, 3, 4 1Non-Communicable Disease and C
Externí odkaz:
https://doaj.org/article/be2f0aef79ea49819d2aaa0b35d6be2b
Autor:
Bosch-Barrera J; Medical Oncology, Catalan Institute of Oncology, Dr. Josep Trueta Hospital of Girona, 17007 Girona, Spain.; Department of Medical Sciences, Medical School, University of Girona, 17003 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain., Roqué A; Medical Oncology, Catalan Institute of Oncology, Dr. Josep Trueta Hospital of Girona, 17007 Girona, Spain., Teixidor E; Medical Oncology, Catalan Institute of Oncology, Dr. Josep Trueta Hospital of Girona, 17007 Girona, Spain., Carmona-Garcia MC; Medical Oncology, Catalan Institute of Oncology, Dr. Josep Trueta Hospital of Girona, 17007 Girona, Spain., Arbusà A; Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, 17007 Girona, Spain., Brunet J; Medical Oncology, Catalan Institute of Oncology, Dr. Josep Trueta Hospital of Girona, 17007 Girona, Spain.; Department of Medical Sciences, Medical School, University of Girona, 17003 Girona, Spain.; Catalan Institute of Oncology, IDIBELL, 08908 L'Hospitalet de Llobregat, Spain., Martin-Castillo B; Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.; Unit of Clinical Research, Catalan Institute of Oncology, 17007 Girona, Spain., Cuyàs E; Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, 17007 Girona, Spain., Verdura S; Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, 17007 Girona, Spain., Menendez JA; Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, 17007 Girona, Spain.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Dec 24; Vol. 15 (1). Date of Electronic Publication: 2021 Dec 24.
Autor:
Bouvier AM; Digestive cancer registry of Burgundy, Dijon, France; Dijon University Hospital, Dijon, France; INSERM UMR 1231, Dijon, France; University of Burgundy, Dijon, France. Electronic address: anne-marie.bouvier@u-bourgogne.fr., Jooste V; Digestive cancer registry of Burgundy, Dijon, France; Dijon University Hospital, Dijon, France; INSERM UMR 1231, Dijon, France; University of Burgundy, Dijon, France., Sanchez-Perez MJ; Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain., Bento MJ; Cancer Epidemiology Group, IPO Porto Research Center (CI-IPOP), Porto, Portugal; Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, (ICBAS-UP), Porto, Portugal., Rocha Rodrigues J; Cancer Epidemiology Group, IPO Porto Research Center (CI-IPOP), Porto, Portugal; Portuguese Oncology Institute of Porto, Porto, Portugal., Marcos-Gragera R; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain; Biomedical Network Research Centers of Epidemiology and Public Health (CIBERESP), Madrid, Spain., Carmona-Garcia MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Dr. Josep Trueta, Girona, Spain; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain., Luque-Fernandez MA; Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Minicozzi P; Analytical Epidemiology and Health Impact Unit, Research Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK., Bouvier V; Digestive tumors registry of Calvados, Caen, France; U1086 INSERM UCN, ANTICIPE, Caen, France; Caen University Hospital, Caen, France., Innos K; Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia., Sant M; Analytical Epidemiology and Health Impact Unit, Research Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 May; Vol. 53 (5), pp. 639-645. Date of Electronic Publication: 2021 Feb 24.
Autor:
García-Velasco A; Medical Oncology Department, Josep Trueta Universitary Hospital, Catalan Institute of Oncology, Av de França, 17007 Girona, Spain.; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), C/Dr. Castany, s/n, 17190 Salt, Spain., Zacarías-Pons L; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Av. França, s/n, 17004 Girona, Spain., Teixidor H; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Av. França, s/n, 17004 Girona, Spain., Valeros M; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Av. França, s/n, 17004 Girona, Spain., Liñan R; Medical Oncology Department, Josep Trueta Universitary Hospital, Catalan Institute of Oncology, Av de França, 17007 Girona, Spain., Carmona-Garcia MC; Medical Oncology Department, Josep Trueta Universitary Hospital, Catalan Institute of Oncology, Av de França, 17007 Girona, Spain.; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), C/Dr. Castany, s/n, 17190 Salt, Spain., Puigdemont M; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), C/Dr. Castany, s/n, 17190 Salt, Spain.; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Av. França, s/n, 17004 Girona, Spain., Carbajal W; Medical Oncology Department, Josep Trueta Universitary Hospital, Catalan Institute of Oncology, Av de França, 17007 Girona, Spain., Guardeño R; Medical Oncology Department, Josep Trueta Universitary Hospital, Catalan Institute of Oncology, Av de França, 17007 Girona, Spain., Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research (CNIO) and CIBERONC, 28029 Madrid, Spain., Duell E; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 08908 Barcelona, Spain., Marcos-Gragera R; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), C/Dr. Castany, s/n, 17190 Salt, Spain.; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Av. França, s/n, 17004 Girona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.
Publikováno v:
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Dec 19; Vol. 17 (24). Date of Electronic Publication: 2020 Dec 19.
Autor:
Carrasco-Peña F; Radiation Oncology Department, University Hospital Virgen Macarena, 41009 Sevilla, Spain., Bayo-Lozano E; Radiation Oncology Department, University Hospital Virgen Macarena, 41009 Sevilla, Spain., Rodríguez-Barranco M; Escuela Andaluza de Salud Pública, 18011 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.; CIBER de Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain., Petrova D; Escuela Andaluza de Salud Pública, 18011 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.; CIBER de Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain., Marcos-Gragera R; CIBER de Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.; Medical Sciences Department, Faculty of Medicine, University of Girona (UdG), 17071 Girona, Spain.; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Department of Health, Government of Catalonia, 17007 Girona, Spain.; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Girona Biomedical Research Institute-IDIBGI, 17190 Salt, Girona, Spain., Carmona-Garcia MC; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Girona Biomedical Research Institute-IDIBGI, 17190 Salt, Girona, Spain.; Medical Oncology Department, Catalan Institute of Oncology, University Hospital Dr Josep Trueta, 17007 Girona, Spain., Borras JM; Department of Clinical Sciences, IDIBELL, University of Barcelona, 08908 Hospitalet, Barcelona, Spain.; Department of Health, Catalonian Cancer Strategy, 08908 Hospitalet, Barcelona, Spain., Sánchez MJ; Escuela Andaluza de Salud Pública, 18011 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.; CIBER de Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.; Department of Preventive Medicine and Public Health, University of Granada, 18010 Granada, Spain.
Publikováno v:
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Sep 14; Vol. 17 (18). Date of Electronic Publication: 2020 Sep 14.
Autor:
Domingo L; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain., Sala M; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain., Louro J; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain., Baré M; Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain.; Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine and Public Health, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Barcelona, Spain.; Cancer Screening and Clinical Epidemiology, Corporació Sanitària Parc Taulí, 08208 Sabadell, Spain., Barata T; General Directorate of Health Care Programmes, Canary Islands Health Service, C/Juan XXIII, 13 35005, Las Palmas de Gran Canaria, Spain., Ferrer J; Department of Radiology, Hospital de Santa Caterina, C/Dr. Castany, s/n, 17190 Salt, Girona, Spain., Carmona-Garcia MC; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Catalan Institute of Oncology, C/Sol, 15, Barcelona 17004, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), C/Dr Castany s/n, 17190 Salt, Girona, Spain.; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Dr. Josep Trueta, Av França s/n, 17007, Barcelona, Girona, Spain., Comas M; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain., Castells X; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain.; Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine and Public Health, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Barcelona, Spain., Camiss Study Group; IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003 Barcelona, Spain.
Publikováno v:
Journal of oncology [J Oncol] 2019 Nov 27; Vol. 2019, pp. 1781762. Date of Electronic Publication: 2019 Nov 27 (Print Publication: 2019).
Autor:
Sala M; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. msalaserra@parcdesalutmar.cat.; Research Network on Health Services in Chronic Diseases (REDISSEC), Spain., Domingo L; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Spain., Louro J; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Spain., Torá-Rocamora I; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Baré M; Research Network on Health Services in Chronic Diseases (REDISSEC), Spain.; Cancer Screening and Clinical Epidemiology, Corporació Sanitària Parc Taulí, Sabadell, Catalonia, Spain.; Department of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and Public Health, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain., Ferrer J; Department of Radiology, Hospital de Santa Caterina, Salt, Girona, Spain., Carmona-Garcia MC; Girona Cancer Registry, University of Girona, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI).; Emergency Department, University Hospital Dr. Josep Trueta, Girona, Spain., Barata T; General Directorate of Health Care Programs, Canary Islands Health Service, Las Palmas de Gran Canaria, Spain., Román M; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Spain., Macià F; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Castells X
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2018 Aug; Vol. 27 (8), pp. 908-916. Date of Electronic Publication: 2018 May 31.
Autor:
Fuentes-Raspall R; Radiation Oncology Service, Josep Trueta University Hospital, Catalan Institute of Oncology, Avinguda de França, S/N, 17007 Girona, Spain. Electronic address: Rfuentes@iconcologia.net., Solans M; CIBER in Epidemiology and Public Health (CIBERESP), University of Girona (UdG), C/ Universitat de Girona 10,17003 Girona, Spain, Spain; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona (UdG), C/ Universitat de Girona 10,17003 Girona, Spain; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Carrer del Sol, 15, 17004 Girona, Spain. Electronic address: martasolans@gmail.com., Roca-Barceló A; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Carrer del Sol, 15, 17004 Girona, Spain. Electronic address: ainarb16@gmail.com., Vilardell L; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Carrer del Sol, 15, 17004 Girona, Spain. Electronic address: mlvilardell@iconcologia.net., Puigdemont M; Hospital Cancer Registry, Josep Trueta University Hospital, Catalan Institute of Oncology, Av de França, 17007, Girona, Spain; Nursing Department, University of Girona, Av de França, 17007, Girona, Spain. Electronic address: mpuigdemont@iconcologia.net., Del Barco S; Medical Oncology Service, Josep Trueta University Hospital, Catalan Institute of Oncology, Av de França, 17007, Girona, Spain. Electronic address: Sdel@iconcologia.net., Comas R; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Carrer del Sol, 15, 17004 Girona, Spain. Electronic address: raquelcomas14@gmail.com., García-Velasco A; Medical Oncology Service, Josep Trueta University Hospital, Catalan Institute of Oncology, Av de França, 17007, Girona, Spain. Electronic address: Agarcia2@iconcologia.net., Astudillo A; Department of Pathology, Central University Hospital of Asturias (HUCA), Av. de Roma, 33006 Oviedo, Spain. Electronic address: astudillo@hca.es., Carmona-Garcia MC; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Carrer del Sol, 15, 17004 Girona, Spain; Emergency Department, Josep Trueta University Hospital, Catalan Institute of Oncology, Av de França, 17007, Girona, Spain. Electronic address: mccarmonagarcia22@gmail.com., Marcos-Gragera R; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona (UdG), C/ Universitat de Girona 10,17003 Girona, Spain; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Carrer del Sol, 15, 17004 Girona, Spain. Electronic address: rmarcos@iconcologia.net.
Publikováno v:
Cancer epidemiology [Cancer Epidemiol] 2017 Oct; Vol. 50 (Pt A), pp. 1-8. Date of Electronic Publication: 2017 Jul 21.